Amanote Research
Register
Sign In
Pcn137 - The Economic Evaluation of Imatinib Combined With Chemotherapy for Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in China
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.220
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
V.W. Wang
Z. Li
Publisher
Elsevier BV
Related search
Prediction of Risk of Disease Recurrence by Genome-Wide cDNA Microarray Analysis in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib-Combined Chemotherapy
International Journal of Oncology
Cancer Research
Oncology
Lymphoblasts Expressing Surface IgM in the Absence of Kappa and Lambda in Philadelphia Positive Acute Lymphoblastic Leukemia: Philadelphia Chromosome Positive Transitional Pre-B Acute Lymphoblastic Leukemia
Clinical Case Reports and Reviews
Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults
American Journal of Hematology
Hematology
Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Clinical and Pathologic Features of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in a Pediatric Patient
Archive of Clinical Cases
Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Drugs and Therapy Studies
Efficacy and Safety of Imatinib Mesylate (Glivec™) in Combination With Interferon-Α (IFN-α) in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Immunologic Characterization of the Tumor-Specific BCR-Abl Junction in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
